Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?

Kotha Sugunakar Reddy; Archana Gaur; Sakthivadivel Varatharajan; Arvind Kumar Morya

doi:10.4239/wjd.v15.i3.565

Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?

World J Diabetes. 2024 Mar 15;15(3):565-567. doi: 10.4239/wjd.v15.i3.565.

Authors

Kotha Sugunakar Reddy¹, Archana Gaur², Sakthivadivel Varatharajan³, Arvind Kumar Morya⁴

Affiliations

¹ Department of General Medicine, All India Institute of Medical Sciences, Hyderabad 508126, Telangana, India.
² Department of Physiology, All India Institute of Medical Sciences, Hyderabad 508126, Telangana, India.
³ Department of Medicine, All India Institute of Medical Sciences, Hyderabad 508126, Telangana, India.
⁴ Department of Ophthalmology, All India Institute of Medical Sciences, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com.

Abstract

This published Meta-Analysis by Lin et al is an indirect comparison between two drugs Chiglitazar and Thiazolidinedione which are commonly used for glycemic control in type-II diabetes mellitus. In terms of safety and efficacy, this Meta-Analysis is inconclusive.

Keywords: Glucose intolerance; Hyperglycemia; Research methodology; Type-II diabetes mellitus.